• Phone: +1-631-791-1145
                  • Email: sales@imarcgroup.com

                  *As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

                  Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

                  Report Overview:

                  The Indian diabetes market reached a value of US$ 2,282 Million in 2019. Diabetes is rapidly gaining the status of a potential epidemic in India with around 65 million people currently being affected by it. The Indian population that had faced under nutrition for a long time is now exposed to over nutrition and sedentary lifestyles. Coupled with a bad nutritional history and the fact that Indians are genetically more vulnerable to diabetes compared to other population groups, India’s struggle with diabetes is expected to be one of the biggest epidemics the country has ever witnessed. Looking forward, the market is expected to witness strong growth during 2020-2025.

                  Indian Diabetes Market

                  India’s diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.

                  IMARC’s new report “Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Indian diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in India. The report has segmented the Indian diabetes market into three segments - Oral Antidiabetics, Insulin and Diabetes Diagnostics. For each of the aforementioned categories, the report provides historical and future market sales, performance of key classes and the performance of top players.

                  The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Indian diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Indian diabetes market in some form or the other.

                  What we have achieved in this report: 

                  Comprehensive situation analysis of the Indian diabetes epidemiology and its dynamics:

                  Focus of the Analysis:

                  • Historical, current and future prevalence of diabetes in India
                  • Historical, current and future prevalence of type-1 and type-2 diabetes in India
                  • Historical, current and future prevalence of diabetes in the urban and rural regions in India
                  • Historical, current and future prevalence of diabetes among males and females in India
                  • Historical, current and future prevalence of diabetes among various age groups in India
                  • Historical, current and future diagnosis rates for diabetes in India
                  • Historical, current and future drug treatment rates for diabetes in India 


                  Comprehensive situation analysis of the Indian Oral Antidiabetics market and its dynamics:

                  Focus of the Analysis:

                  • Performance of the Oral Antidiabetics market in India
                  • Performance of key classes
                  • Performance of key players
                  • Market outlook 


                  Comprehensive situation analysis of the Indian Insulin market and its dynamics:

                  Focus of the Analysis:

                  • Performance of the Insulin market in India
                  • Performance of key classes
                  • Performance of key players
                  • Market outlook 


                  Comprehensive situation analysis of the diabetes diagnostics market and its dynamics:

                  Focus of the Analysis:

                  • Performance of the diabetes diagnostics market in India
                  • Impact of COVID-19 on the Oral Antidiabetics market
                  • Performance of key classes
                  • Performance of key players
                  • Market outlook

                  1   Preface
                  2   Scope and Methodology

                      2.1    Objectives of the Study
                      2.2    Stakeholders
                      2.3    Data Sources
                          2.3.1    Primary Sources
                          2.3.2    Secondary Sources
                      2.4    Market Estimation
                          2.4.1    Bottom-Up Approach
                          2.4.2    Top-Down Approach
                      2.5    Forecasting Methodology
                  3   Executive Summary
                  4   Diabetes Disease Overview

                      4.1 What is Diabetes?
                      4.2 Diabetes Diagnosis and Treatment
                          4.2.1 Diagnosis
                          4.2.2 Treatment
                      4.3 Diabetes Complications
                  5   Factors Driving the Diabetes Market in India
                      5.1 Increasing Obesity Levels
                      5.2 Urbanization
                      5.3 Impact of COVID-19
                      5.4 India has the Second Largest Diabetes Patient Base in the World
                      5.5 India Represents One of the Fastest Growing Markets Globally
                      5.6 Improving Diagnosis and Treatment Rates
                  6   The Indian Diabetes Epidemiology
                      6.1 Diabetes Population and Prevalence Rates
                      6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
                      6.3 Population and Prevalence Rates by Region (Urban and Rural)
                      6.4 Population and Prevalence Rates by Gender
                      6.5 Population and Prevalence Rates by Age Group
                      6.6 Diabetes Diagnosis and Drug Treatment Rates
                  7   Indian Diabetes Market
                      7.1 Historical Market Trends (2014-2019)
                      7.2 Market Breakup by Segment (2014-2019)
                      7.3 Indian Oral Antidiabetics Market
                          7.3.1 Historical Market Trends (2014-2019)
                          7.3.2 Market Breakup by Class (2014-2019)
                          7.3.3 Market Shares of Key Players
                          7.3.4 Market Outlook (2020 - 2025)
                      7.4 Indian Insulin Market
                          7.4.1 Historical Market Trends (2020 - 2025)
                          7.4.2 Market Breakup by Class
                          7.4.3 Market Shares of Key Players
                          7.4.4 Market Outlook (2020 - 2025)
                      7.5 Market Outlook (2020 - 2025)
                  8   Indian Diabetes Diagnostics Market
                      8.1 Historical Market Trends (2014-2019)
                      8.2 Market Breakup by Product Type
                      8.3 Key Players
                      8.4 Market Outlook (2020 - 2025)
                  9   SWOT Analysis
                      9.1 Overview
                      9.2 Strengths
                      9.3 Weaknesses
                      9.4 Opportunities
                      9.5 Threats
                  10  Value Chain Analysis
                  11  Porter’s Five Forces

                      11.1 Overview
                      11.2 Bargaining Power of Buyers
                      11.3 Bargaining Power of Suppliers
                      11.4 Degree of Competition
                      11.5 Threat of New Entrants
                      11.5 Threat of Substitutes
                  12  Competitive Landscape
                      12.1 Competitive Structure
                      12.2 Key Player Profiles


                  List of Figures

                  Figure 4-1: The Impact of Diabetes on the Human Body
                  Figure 4-2: Diabetes Complications
                  Figure 4-3: India: Overweight & Obese Population (in Million), 2014, 2019 & 2025
                  Figure 5-2: Body Mass Index and Relative Risk of Type-2 Diabetes
                  Figure 5-3: Global: Breakup of Diabetes Patients by Region (in %), 2019 & 2025
                  Figure 6-1: India: Total Number of Diabetes Patients (in Millions), 2014-2019
                  Figure 6-2: India: Total Number of Diabetes Patients Forecast (in Millions), 2020 - 2025
                  Figure 6-3: India (Type1 & Type2): Total Number of Diabetes Patients (in Millions), 2014-2019
                  Figure 6-4: India (Type1 & Type2): Total Number of Diabetes Patients Forecast (in Millions) 2020 - 2025
                  Figure 6-5: India (Urban & Rural): Total Number of Diabetes Patients (in Millions), 2014-2019
                  Figure 6-6: India (Urban & Rural): Total Number of Diabetes Patients Forecast (in Millions), 2020 - 2025
                  Figure 6-7: India (Male & Female): Total Number of Diabetes Patients (in Millions), 2014-2019
                  Figure 6-8: India (Male & Female): Total Number of Diabetes Patients Forecast (in Millions), 2020 - 2025 
                  Figure 6-9: India: Total Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79-in Million), 2014 - 2019
                  Figure 6-10: India: Total Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79-in Million), 2020 - 2025
                  Figure 6-11: India: Total Diagnosed & Drug Treated Diabetes Population (in Millions), 2014-2019
                  Figure 6-12: India: Total Diagnosed & Drug Treated Diabetes Population Forecast (in Millions), 2020 - 2025
                  Figure 7-1: India: Diabetes Market (in Million US$), 2014-2019
                  Figure 7-2: India: Diabetes Market: Share of Oral Antidiabetics and Insulin (in %), 2014-2019
                  Figure 7-3: India: Oral Antidiabetics Market (in Million US$), 2014-2019
                  Figure 7-4: India: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2014-2019
                  Figure 7-5: India: Oral Antidiabetics Market: Sales Share of Key Players (in %)
                  Figure 7-6: India: Oral Antidiabetics Market Forecast (in Million US$), 2020 - 2025
                  Figure 7-7: India: Insulin Market (in Million US$), 2014-2019
                  Figure 7-8: India: Insulin Market: Sales Share of Key Classes (in %)
                  Figure 7-9: India: Insulin Market: Sales Share of Key Players (in %)
                  Figure 7-10: India: Insulin Market Forecast (in Million US$), 2020 - 2025
                  Figure 7-11: India: Diabetes Market Forecast (in Million US$), 2020 - 2025
                  Figure 7-12: India: Diabetes Market Forecast: Share of Oral Antidiabetics and Insulin (in %), 2020 - 2025
                  Figure 8-1: India: Glucose Monitoring Market (in Million US$), 2014-2019
                  Figure 8-2: India: Glucose Monitoring Market: Sales Share by Segment (in %)
                  Figure 8-3: India: Glucose Monitoring Market: Sales Share of Key Players (in %)
                  Figure 8-4: India: Glucose Monitoring Market Forecast (in Million US$), 2020 - 2025
                  Figure 9-1: Indian: Diabetes Market: SWOT Analysis
                  Figure 10-1: Indian: Diabetes Market: Value Chain Analysis
                  Figure 11-1: Indian: Diabetes Market: Porter’s Five Forces Analysis


                  List of Tables

                  Table 2-1: India: Diabetes Market: Industry Overview
                  Table 3-1: Diagnosis of Diabetes
                  Table 4-1: India: Overweight & Obesity Statistics, 2005, 2010 & 2019
                  Table 4-2: India: Urban & Rural Population Breakup (in Million), 1992, 2001, 2011
                  Table 4-3: Global: Diabetes Population Breakup by Country (in 000’s), 2019 & 2025
                  Table 4-4: Global: Market Size & Growth Rates of Top Emerging and Developed Diabetes Drug Markets
                  Table 5-1: India: Total Prevalence & Number of Diabetes Patients (in Million), 2014, 2019 & 2025
                  Table 5-2: India (Type1 & Type2): Total Prevalence & Number of Diabetes Patients (in Million), 2014, 2019 & 2025
                  Table 5-3: India (Urban & Rural): Total Prevalence & Number of Diabetes Patients (in Million), 2014, 2019 & 2025
                  Table 5-4: India (Male & Female): Total Prevalence & Number of Diabetes Patients (in Million), 2014, 2019 & 2025
                  Table 5-5: India: Total Prevalence & Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79- in Million), 2014, 2019 & 2025
                  Table 5-6: India: Total Diagnosed & Drug Treated Diabetes Population (in Million), 2014, 2019 & 2025
                  Table 7-1: India: Diabetes Market: Key Industry Highlights 2019 and 2025
                   

                  Note: We value your privacy and will never rent or sell your email address. Privacy policy

                  Purchase Options




                  $ 1999

                  REACH OUT TO US

                  Call us on

                  ( US: +1-631-791-1145 )
                  ( UK: +44-702-409-7331 )
                  ( India: +91-120-433-0800 )


                  Drop us an email at

                  sales@imarcgroup.com

                  Social Links

                  大芭蕉天天视频在线观看